Cite
MLA Citation
Yaya Chu et al.. “Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation, in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.” Oncoimmunology, vol. 8, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100075217992.0x000009